Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
In both univariate logistic regression analysis (OR: 2.46, 95% CI: 1.06 to 5.68; P = 0.036) and multivariate logistic regression analysis (OR: 2.54, 95% CI: 1.02 to 6.33; P = 0.046), the 25(OH)D3 < 20 ng/ml demonstrated to be a significant risk factor of primary endpoints for those hypertensive patients.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The participants were not included when there was a record of cardiac arrest, severe dyspnea, severe liver disease (including cirrhosis), renal failure (including dialysis), serious infection recently, and other granulomatous diseases.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Associations of vitamin D with coronary revascularization and heart rate variability in hypertensive patients
Study design awaiting verification · Frontiers in Cardiovascular Medicine · 2025
Original publication title
Associations of vitamin D with coronary revascularization and heart rate variability in hypertensive patients
© 2025 Li, Zou, Li and Zhang.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Even though substantial evidence has found that vitamin D deficiency correlates to risk factors for cardiovascular disease (CVD), few studies have shown how vitamin D affects coronary revascularization and heart rate variability (HRV). We aimed to explore the connection between vitamin D levels with coronary revascularization and HRV in hypertensive patients.
Source: BackgroundAbstract: What methods does the paper describe?
A total of the 250 eligible participants with hypertension hospitalized at the Department of Cardiology, Sixth Medical Center of Chinese PLA General Hospital was consecutively recruited. The status of vitamin D is measured utilizing serum 25-hydroxyvitamin D3 [25(OH)D3] concentrations. The primary endpoints were defined as patients undergoing coronary revascularization treatment. The secondary endpoints were defined as the variation in HRV. HRV indices were recorded in participants using a 24-h Holter electrocardiogram (ECG). In addition, direct renin concentrations and plasma aldosterone concentrations were measured in the supine and standing positions.
Source: MethodsAbstract: Results
In the study, 165 eligible patients assigned to the vitamin D deficiency [25(OH)D3 < 20 ng/ml] group and 85 to the vitamin D non-deficiency[25(OH)D3 ≥ 20 ng/ml] group. In both univariate logistic regression analysis (OR: 2.46, 95% CI: 1.06 to 5.68; P = 0.036) and multivariate logistic regression analysis (OR: 2.54, 95% CI: 1.02 to 6.33; P = 0.046), the 25(OH)D3 < 20 ng/ml demonstrated to be a significant risk factor of primary endpoints for those hypertensive patients. Receiver operating characteristic curve (ROC) analysis showed the multivariable-adjusted model for predicting primary endpoints in patients with hypertension, with an area under the curve (AUC) of 0.73 (95% CI: 0.64 to 0.82, p < 0.001).
Regarding secondary endpoints, the HRV indexes such as standard deviation of normal-to-normal (NN) intervals (SDNN) (P = 0.04), standard deviation of the averages of NN intervals in all 5-min segments (SDANN) (P = 0.03), and Triangle indexes values (P = 0.02) were significantly different in the two groups. Finally, we observed that hypertensive patients with vitamin D deficiency had significantly greater aldosterone and aldosterone-to-renin ratio (ARR) values than those having vitamin D non-deficiency.
Source: ResultsAbstract: Conclusion
Vitamin D deficiency was prevalent in hypertensive patients and was independently associated with the risk of coronary revascularization. Vitamin D deficiency also affects HRV and ARR values in hypertensive patients.
Source: ConclusionAuthors’ abstract
Background
Even though substantial evidence has found that vitamin D deficiency correlates to risk factors for cardiovascular disease (CVD), few studies have shown how vitamin D affects coronary revascularization and heart rate variability (HRV). We aimed to explore the connection between vitamin D levels with coronary revascularization and HRV in hypertensive patients.
Methods
A total of the 250 eligible participants with hypertension hospitalized at the Department of Cardiology, Sixth Medical Center of Chinese PLA General Hospital was consecutively recruited. The status of vitamin D is measured utilizing serum 25-hydroxyvitamin D3 [25(OH)D3] concentrations. The primary endpoints were defined as patients undergoing coronary revascularization treatment. The secondary endpoints were defined as the variation in HRV. HRV indices were recorded in participants using a 24-h Holter electrocardiogram (ECG). In addition, direct renin concentrations and plasma aldosterone concentrations were measured in the supine and standing positions.
Results
In the study, 165 eligible patients assigned to the vitamin D deficiency [25(OH)D3 < 20 ng/ml] group and 85 to the vitamin D non-deficiency[25(OH)D3 ≥ 20 ng/ml] group. In both univariate logistic regression analysis (OR: 2.46, 95% CI: 1.06 to 5.68; P = 0.036) and multivariate logistic regression analysis (OR: 2.54, 95% CI: 1.02 to 6.33; P = 0.046), the 25(OH)D3 < 20 ng/ml demonstrated to be a significant risk factor of primary endpoints for those hypertensive patients. Receiver operating characteristic curve (ROC) analysis showed the multivariable-adjusted model for predicting primary endpoints in patients with hypertension, with an area under the curve (AUC) of 0.73 (95% CI: 0.64 to 0.82, p < 0.001).
Regarding secondary endpoints, the HRV indexes such as standard deviation of normal-to-normal (NN) intervals (SDNN) (P = 0.04), standard deviation of the averages of NN intervals in all 5-min segments (SDANN) (P = 0.03), and Triangle indexes values (P = 0.02) were significantly different in the two groups. Finally, we observed that hypertensive patients with vitamin D deficiency had significantly greater aldosterone and aldosterone-to-renin ratio (ARR) values than those having vitamin D non-deficiency.
Conclusion
Vitamin D deficiency was prevalent in hypertensive patients and was independently associated with the risk of coronary revascularization. Vitamin D deficiency also affects HRV and ARR values in hypertensive patients.
Publication and source details
Original title: Associations of vitamin D with coronary revascularization and heart rate variability in hypertensive patients
Zongbin Li; Yuting Zou; Ruizhe Li; Minglei Zhang
Frontiers in Cardiovascular Medicine · 2025
Edited by: Jelena Milešević, University of Belgrade, Serbia
Reviewed by: William B. Grant, Sunlight Nutrition and Health Research Center, United States
Dolina Gencheva, Plovdiv Medical University, Bulgaria
These authors have contributed equally to this work and share first authorship
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:06:21.748165+00:00
DOI: 10.3389/fcvm.2025.1590701 · PMC12491254